Royalty Pharma(RPRX)
$69.31+0.58 (+0.84%)
RPRX
Royalty Pharma earnings date
$69.31
At close:+0.58 (+0.84%)
Want to see RPRX full AI Analyst Report?
Royalty Pharma (RPRX) Q2 2023 Earnings Report
1,359 Followers
RPRX Q2 2023 EPS Results
- Actual EPS
- $0.85
- Consensus EPS
- $0.83
- Beat/Miss
- Beat by +$0.02
- One Year Ago EPS
- $0.81
RPRX Q2 2023 Revenue Results
- Actual Revenue
- $538.20M
- Expected Revenue
- $543.70M
- Beat/Miss
- Missed by -$5.49M
- YoY Revenue Growth
- +0.42%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/08/2023
- Time
- Before Open
- Conference Call
- Tuesday, August 8, 2023
RPRX Upcoming Earnings
Royalty Pharma's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
RPRX Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
RPRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 1.57- | 1.47 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 1.181.21 | 1.17 | 2.98% (+0.04) | |
| Aug 05, 2026 | 2026 (Q2) | 1.271.32 | 1.14 | 15.78% (+0.18) | |
| May 06, 2026 | 2026 (Q1) | 1.211.30 | 0.75 | 73.03% (+0.55) | |
| Feb 11, 2026 | 2025 (Q4) | 1.291.47 | 1.15 | 27.37% (+0.32) | |
| Nov 05, 2025 | 2025 (Q3) | 0.991.17 | 0.92 | 27.92% (+0.26) | |
| Aug 06, 2025 | 2025 (Q2) | 1.031.14 | 0.96 | 18.73% (+0.18) | |
| May 08, 2025 | 2025 (Q1) | 0.950.75 | 0.98 | -23.42% (-0.23) | |
| Feb 11, 2025 | 2024 (Q4) | 1.051.15 | 1.15 | 0.17% (+0.00) | |
| Nov 06, 2024 | 2024 (Q3) | 0.930.92 | 0.79 | 16.22% (+0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


